We are live on ! Find out more
ICM

Invenomic Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 0.03%
This Fund
S&P 500
This Quarter Est. Return
-8.85%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
AUM
$1.16B
AUM Growth
-$246M
Cap. Flow
-$108M
Cap. Flow %
-9.27%
Top 10 Hldgs %
23.33%
Holding
205
New
58
Increased
35
Reduced
52
Closed
59

Top Buys

Rank Stock Value
1
ZM icon
Zoom
ZM
+$22.3M
2
VNT icon
Vontier
VNT
+$21.7M
3
SSNC icon
SS&C Technologies
SSNC
+$21.3M
4
IPGP icon
IPG Photonics
IPGP
+$21.3M
5
BKNG icon
Booking.com
BKNG
+$20.1M

Sector Composition

Rank Sector Weight
1 Technology 30.14%
2 Consumer Discretionary 16.46%
3 Communication Services 11.87%
4 Industrials 9.35%
5 Healthcare 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OSK icon
26
Oshkosh
OSK
$9.57B
$14.2M 1.22%
201,946
+163,012
+419% +$13.3M
HRT
27
DELISTED
HireRight Holdings Corporation
HRT
$13.9M 1.2%
914,019
-30,962
-3% -$490K
WEX icon
28
WEX
WEX
$6.37B
$13.8M 1.18%
+108,484
New +$17.1M
LEVI icon
29
Levi Strauss
LEVI
$9.24B
$13.7M 1.18%
947,805
+120,329
+15% +$2.15M
SANM icon
30
Sanmina
SANM
$10.9B
$13.3M 1.15%
289,325
-81,289
-22% -$3.79M
NVEI
31
DELISTED
Nuvei Corporation Subordinate Voting Shares
NVEI
$13.3M 1.14%
491,853
+136,478
+38% +$4.45M
CLS icon
32
Celestica
CLS
$36.6B
$12.5M 1.07%
1,482,081
+209,196
+16% +$2.12M
LYFT icon
33
Lyft
LYFT
$6.58B
$12M 1.03%
908,107
+446,527
+97% +$6.87M
VZ icon
34
Verizon
VZ
$195B
$11.8M 1.01%
+310,294
New +$13.8M
HSII
35
DELISTED
Heidrick & Struggles
HSII
$11.6M 1%
447,377
-12,673
-3% -$374K
PRGO icon
36
Perrigo
PRGO
$1.73B
$11.6M 0.99%
+324,253
New +$13M
FISV
37
Fiserv Inc
FISV
$27.6B
$11.3M 0.97%
121,104
-3,432
-3% -$350K
FUN icon
38
Cedar Fair
FUN
$1.67B
$11M 0.94%
266,311
+236,286
+787% +$10.1M
ROVR
39
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
$10.8M 0.93%
3,245,940
-109,293
-3% -$435K
TTE icon
40
TotalEnergies
TTE
$194B
$10.8M 0.92%
+231,315
New +$11.6M
OC icon
41
Owens Corning
OC
$12.2B
$10.1M 0.86%
127,895
-3,626
-3% -$305K
ABM icon
42
ABM Industries
ABM
$2.83B
$9.89M 0.85%
258,816
+109,793
+74% +$4.81M
OEC icon
43
Orion
OEC
$391M
$9.58M 0.82%
717,794
-20,350
-3% -$331K
UBER icon
44
Uber
UBER
$159B
$9.25M 0.79%
349,112
-384,630
-52% -$10.6M
IMMR icon
45
Immersion
IMMR
$255M
$9.16M 0.79%
1,669,161
VTRS icon
46
Viatris
VTRS
$18.8B
$8.97M 0.77%
+1,053,366
New +$10.4M
BLCO icon
47
Bausch + Lomb
BLCO
$6.03B
$8.91M 0.77%
580,864
-16,481
-3% -$262K
CHRD icon
48
Chord Energy
CHRD
$7.69B
$8.86M 0.76%
+64,756
New +$8.31M
PVH icon
49
PVH
PVH
$4.01B
$8.56M 0.74%
191,012
-5,363
-3% -$318K
PLCE icon
50
Children's Place
PLCE
$57.8M
$7.91M 0.68%
256,067
-7,228
-3% -$304K

Similar funds

Invenomic Capital Management's Q3 2022 Portfolio in Review

As of Q3 2022, Invenomic Capital Management held 205 positions worth $1.16B, down 17% from $1.41B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Invenomic Capital Management withdrew a net $108M in Q3 2022, closing 59 positions and reducing 52 holdings. Its most notable exit was Cardinal Health, an estimated $17.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, Invenomic Capital Management opened a new position in Zoom worth $17.2M.

  • Invenomic Capital Management's largest Q3 2022 buy was Zoom: 234,351 shares worth $17.2M.
  • Invenomic Capital Management added most to IPG Photonics in Q3 2022, an estimated $21.3M increase.
  • Invenomic Capital Management's biggest Q3 2022 reduction was Belden, cutting an estimated $13.5M.
  • Invenomic Capital Management fully exited Cardinal Health in Q3 2022, selling an estimated $17.9M.
  • Invenomic Capital Management's ten largest holdings make up 23% of its $1.16B portfolio in Q3 2022.
  • Invenomic Capital Management opened 58 new positions and closed 59 in Q3 2022.
  • Invenomic Capital Management's portfolio value fell 17% quarter-over-quarter to $1.16B.

Based on Invenomic Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.